GERİATRİDE RADYOTERAPİ

Öz

İnsan ömrü uzamaktadır, bu nedenle Geriatrik hasta sayısında artış beklenmektedir. Geriatrik hastalarda radyoterapi RT uygulamaları geçmişte cesaret vericidir. Radyoterapinin tümör ve mikro çevrede etkileri daha iyi anlaşılabilmektedir. Son dönemde Radyasyon Onkolojisi alanında teknolojik ve tedavi etkinliği 3D-CRT, IMRT, SBRT, Tomoterapi, Proton RT, Brakiterapi ve Hipofraksiyone RT radyasyonun yan etkilerini ve süresini azaltmış ve tümör tedavi etkinliğini arttırmıştır. Geriatride RT etkinliğini olumlu yönde güncellemek gerekmektedir. Bu derlemede geriatrik hastalarda radyasyonun biyolojik ve toksik etkileri, geçmişte yapılan tedavilerin etki ve sonuçları, yeni teknolojik gelişmelerin etkisiyle günümüzdeki RT seçenekleri ve güncellenmesi gereken hususlara vurgu yapılmıştır

Anahtar Kelimeler

• Geriatri,Radyoterapi

GERIATRIC RADIOTHERAPY

Öz

Human life is increased, so it is expected to increase in the number of geriatric patients. Radiotherapy RT applications in the past in geriatric patients has been encouraging. Effects of radiotherapy and the tumor micro-environment can be better understood. Recently, technological and therapeutic efficacy in the Radiation Oncology field of 3D-CRT, IMRT, SBRT, Tomotherapy, Proton RT, Brachytherapy and Hypofractionated RT reduce the side effects of radiation and its duration and increased tumor efficacy. RT effect is required to update for geriatric in a positive way. In this review, biological and toxic effects of radiation in geriatric patients and the results of treatment which has been given in the past, emphasize to the issues of the impact of new technological developments and should be updated with current RT options

Anahtar Kelimeler

• Geriatrics,Radiotherapy

Kaynakça

1. )Chen MJ, Nadalin W. Peculiarities of radiotherapy in the el- derly. Radiol Bras. 2010; 43: 324-29.
2. )Paulino AC, Constine LS, Rubin P, et al. Normal tissue develop- ment, homeostasis, senescence, and the sensitivity to radiation in- jury across the age spectrum. Semin Radiat Oncol. 2010; 20: 12-20.
3. )Mitsuhashi N, Hayakawa K, Yamakawa M, et al. Cancer in pa- tients aged 90 years or older: radiation therapy. Radiology. 1999; : 829-33.
4. )Yamakawa M, Shiojima K, Takahashi M, Saito Y, et al. Radiati- on therapy for esophageal cancer in patients over 80 years old. Int J Radiat Oncol Biol Phys. 1994; 30: 1225-32.
5. )Zachariah B, Balducci L, Venkattaramanabalaji GV, et al. Ra- diotherapy for cancer patients aged 80 and older: a study of ef- fectiveness and side effects. Int J Radiat Oncol Biol Phys. 1997; : 1125-29.
6. )Hishikawa Y, Kurisu K, Taniguchi M, et al. Radiotherapy for carcinoma of the esophagus in patients aged eighty or older. Int J Radiat Oncol Biol Phys. 1991; 20: 685-88.
7. )Pignon T, Horiot JC, Van den Bogaert W, et al. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer. ; 32: 2075-81.
8. )Pignon T, Horiot JC, Bolla M, et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol. ; 42: 107-20. )Chin R, Fisher RJ, Smee RI, et al. Oropharyngeal cancer in the elderly. Int J Radiat Oncol Biol Phys. 1995; 32: 1007-16.

9. )Lusinchi A, Bourhis J, Wibault P, et al. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys. ; 18: 819-23. )Pignon T, Gregor A, Schaake Koning C, et al. Age has no im- pact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol. 1998; 46: 239-48.
10. )Nanda RH, Liu Y, Gillespie TW, et al. Stereotactic body ra- diation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A Na- tional Cancer Data Base analysis. Cancer. 2015; doi: 10.1002/ cncr.29640.
11. )Okonogi N, Katoh H, Kawamura H, et al. Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: Comparison with patients under 80 years of age. J Radiat Res. 2015 Aug 27. pii: rrv040.
12. )Bentzen SM, Constine LS, Deasy JO, et al. titative Analyses of Normal Tissue Effects in the Clinic (QUAN- TEC): An Introduction to the Scientific Issues. Int. J. Radiation Oncology Biol. Phys. 2010; 76: Supplement, S3–S9.
13. )Kunkler IH, Audisio R, Belkacemi Y, et al. SIOG Radiothe- rapy Task Force. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task for- ce. Ann Oncol. 2014; 25: 2134-46.
14. )Smith GL, Smith BD. Radiation Treatment in Older Patients: A Framework for Clinical Decision Making. J Clin Oncol. 2014; : 2669-78.
15. )Kılıç S. Tedavi için Gerekli Sayı (TGS) ve Zarar, İstenmeyen Durum için Gerekli Sayı (ZGS) Kavramları Klinisyene Ne Mesaj- lar Veriyor? Journal of Mood Disorders. 2012; 2: 91-94. Quan